Scholarlink

<p>Moyamoya disease (MMD) is a progressive cerebrovascular disorder characterized by chronic steno-occlusive changes of the intracranial carotid circulation. Cognitive decline is increasingly recognized in these patients, even in the absence of overt ischemic events. Reliable neuroimaging markers that capture both disease severity and neurocognitive status are urgently needed to inform clinical decision-making and surgical timing. Given the pivotal role of the choroid plexus in glymphatic clearance and the reported glymphatic impairment in MMD, we hypothesized that choroid plexus volume (CPV) would be increased in MMD patients and associated with both cognitive performance and angiographic severity.In this prospective study, 41 newly diagnosed adult MMD patients and 19 demographically matched healthy controls underwent high-resolution structural MRI and standardized neuropsychological testing. CPV was segmented, normalized to intracranial volume (ICV), and correlated with cognitive performance. Disease severity was staged using magnetic resonance angiography (MRA).CPV was significantly increased in MMD patients compared with controls (1.42 ± 0.39 vs. 1.18 ± 0.30; p = 0.021). Larger CPV was associated with worse working memory (r = −0.298; p = 0.021) and impaired calculation ability (r = −0.282; p= 0.029). Moreover, CPV was positively correlated with more advanced bilateral MRA stages, suggesting that choroid plexus enlargement parallels disease progression.Choroid plexus enlargement reflects both neurocognitive dysfunction and angiographic severity in MMD. As a potential imaging biomarker, CPV may complement conventional vascular assessment, facilitate early risk stratification, and support neurosurgical treatment planning.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Choroid plexus enlargement correlates with cognitive dysfunction and disease progression in Moyamoya disease

  • 期刊论文

  • 发表日期：

    2025年12月27日

查看全文
  • Pengjun Jiang,
  • Ziqi Liu,
  • Huiyou Chen,
  • Chaoran Shen,
  • Junze Zhang,
  • Xiaokuan Hao,
  • Jinhao Lv,
  • Qi Duan,
  • Xinlin Zhou,
  • Xin Lou,
  • Chengcheng Zhu,
  • Shuo Wang,
  • Tao Yu,
  • Rong Wang

摘要

Moyamoya disease (MMD) is a progressive cerebrovascular disorder characterized by chronic steno-occlusive changes of the intracranial carotid circulation. Cognitive decline is increasingly recognized in these patients, even in the absence of overt ischemic events. Reliable neuroimaging markers that capture both disease severity and neurocognitive status are urgently needed to inform clinical decision-making and surgical timing. Given the pivotal role of the choroid plexus in glymphatic clearance and the reported glymphatic impairment in MMD, we hypothesized that choroid plexus volume (CPV) would be increased in MMD patients and associated with both cognitive performance and angiographic severity.In this prospective study, 41 newly diagnosed adult MMD patients and 19 demographically matched healthy controls underwent high-resolution structural MRI and standardized neuropsychological testing. CPV was segmented, normalized to intracranial volume (ICV), and correlated with cognitive performance. Disease severity was staged using magnetic resonance angiography (MRA).CPV was significantly increased in MMD patients compared with controls (1.42 ± 0.39 vs. 1.18 ± 0.30; p = 0.021). Larger CPV was associated with worse working memory (r = −0.298; p = 0.021) and impaired calculation ability (r = −0.282; p= 0.029). Moreover, CPV was positively correlated with more advanced bilateral MRA stages, suggesting that choroid plexus enlargement parallels disease progression.Choroid plexus enlargement reflects both neurocognitive dysfunction and angiographic severity in MMD. As a potential imaging biomarker, CPV may complement conventional vascular assessment, facilitate early risk stratification, and support neurosurgical treatment planning.